DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

References

Spyropoulos AC, Lipardi C, Xu J. et al.
Improved benefit risk profile of rivaroxaban in a subpopulation of the MAGELLAN study.

Clin Appl Thromb Hemost 2019;
25: 1076029619886022 (e-pub ahead of print)
DOI: 10.1177/1076029619886022.

Download Bibliographical Data

Search in: